La vente libre des produits OTC : une liberté à surveiller de près dans la sécurité du monopole pharmaceutique (notice n° 135198)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02822cam a2200409 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112021249.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Espesson-Vergeat, Béatrice |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | La vente libre des produits OTC : une liberté à surveiller de près dans la sécurité du monopole pharmaceutique |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2019.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 86 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | La vente libre des produits de « PMF » reste un acte dont l’encadrement par le monopole pharmaceutique est discuté, mais nécessaire à assurer la protection du « patient consommateur » qui n’a pas la compétence d’un professionnel de santé. Les risques de l’automédication liés à l’usage inapproprié du produit nécessitent une surveillance des conditions et modalités d’acquisition du produit par un consommateur, qui est souvent peu ou mal informé sur les risques du médicament. Les risques liés à l’automédication explique la nécessité de maintenir voir renforcer les conditions et modalités d’accès par le patient au produit en vente libre par précaution au nom de la protection de la santé publique, notion autour de laquelle les autorités de santé et de concurrence devront se retrouver. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Free sale of OTC products remains an act whose supervision by the pharmaceutical monopoly is discussed, but necessary to ensure the protection of the “consumer patient” who does not have the competence of a health professional. The risks of self-medication related to the inappropriate use of the product require a monitoring of the terms and conditions of acquisition of the product by a consumer, who is often poorly or badly informed about the risks of the drug. The risks associated with self-medication explain the need to maintain the conditions and methods of access by the patient to the over-the-counter product as a precaution in the name of the protection of public health, a concept around which health authorities and competition authorities will have to come together. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | médicaments |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | autorité de concurrence |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vente en ligne |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vente libre |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | autorité de santé |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | précaution |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | monopole pharmaceutique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | pharmacie |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | santé publique |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | effets indésirables |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | competition authority |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | public health |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | online sales |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | adverse effects |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | health authority |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | pharmacy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | over-the-counter |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | precaution |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | drugs |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | pharmaceutical monopoly |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Droit, Santé et Société | 3-4 | 3 | 2019-03-17 | p. 13-16 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-droit-sante-et-societe-2018-3-page-13?lang=fr">https://shs.cairn.info/revue-droit-sante-et-societe-2018-3-page-13?lang=fr</a> |
Pas d'exemplaire disponible.
Réseaux sociaux